Jacobi Capital Management LLC Pfizer Inc Transaction History

Jacobi Capital Management LLC

$1.3 Billion
Q4 2024

A detailed history of Jacobi Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Jacobi Capital Management LLC holds 124,916 shares of PFE stock, worth $3.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

124,916

Previous 124,002 0.74%

Holding current value

$3.3 Million

Previous $3.59 Million 7.64%

% of portfolio

0.26%

Previous 0.28%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$24.8 - $30.19 $22,667 - $27,593	914 Added 0.74%	124,916 $3.31 Million
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $55,815 - $63,250	2,015 Added 1.65%	124,002 $3.59 Million
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $21,546 - $25,248	853 Added 0.7%	121,987 $3.41 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $8,388 - $9,632	324 Added 0.27%	121,134 $3.36 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $102,011 - $132,501	3,904 Added 3.34%	120,810 $3.48 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $141,388 - $165,269	4,406 Added 3.92%	116,906 $3.88 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $33,844 - $39,157	937 Added 0.84%	112,500 $4.13 Million
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $151,533 - $197,274	-3,847 Reduced 3.33%	111,563 $4.55 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $235,052 - $306,835	5,630 Added 5.13%	115,410 $5.92 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $170,707 - $208,391	3,901 Added 3.68%	109,780 $4.8 Million
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $65,886 - $78,120	-1,416 Reduced 1.32%	105,879 $5.55 Million
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $76,539 - $94,842	1,673 Added 1.58%	107,295 $5.56 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $64,293 - $95,305	1,556 Added 1.5%	105,622 $6.24 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $68,883 - $88,487	1,755 Added 1.72%	104,066 $4.48 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $25,280 - $28,638	704 Added 0.69%	102,311 $4.01 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $134,730 - $151,948	4,023 Added 4.12%	101,607 $3.68 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $322,148 - $409,640	-9,625 Reduced 8.98%	97,584 $3.61 Million
Q3 2020 Oct 30, 2020	BUY	$31.75 - $37.25 $619,982 - $727,380	19,527 Added 22.27%	107,209 $3.98 Million
Q2 2020 Aug 04, 2020	BUY	$30.12 - $36.54 $2.35 Million - $2.85 Million	77,913 Added 797.55%	87,682 $3.73 Million
Q2 2020 Jul 27, 2020	SELL	$30.12 - $36.54 $2.92 Million - $3.54 Million	-97,007 Reduced 90.85%	9,769 $3.73 Million
Q1 2020 Apr 24, 2020	BUY	$27.03 - $38.62 $80,116 - $114,469	2,964 Added 2.86%	106,776 $3.59 Million
Q4 2019 Feb 03, 2020	BUY	$32.92 - $37.36 $141,292 - $160,349	4,292 Added 4.31%	103,812 $4.08 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $6,887 - $8,931	-212 Reduced 0.21%	99,520 $3.59 Million
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $1.08 Million - $1.21 Million	29,202 Added 41.4%	99,732 $4.32 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $232,275 - $255,192	6,194 Added 9.63%	70,530 $3 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $574,010 - $654,435	14,921 Added 30.2%	64,336 $2.81 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $44,983 - $54,562	1,305 Added 2.71%	49,415 $2.18 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $126,379 - $134,733	3,832 Added 8.65%	48,110 $1.75 Million
Q1 2018 May 03, 2018	BUY	$31.91 - $37.02 $255,184 - $296,048	7,997 Added 22.04%	44,278 $1.55 Million
Q4 2017 Feb 05, 2018	BUY	$33.26 - $35.29 $3,891 - $4,128	117 Added 0.32%	36,281 $1.32 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $24,986 - $27,524	806 Added 2.28%	36,164 $1.31 Million
Q2 2017 Aug 10, 2017	BUY	N/A	35,358	35,358 $1.18 Million

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.

Account

Jacobi Capital Management LLC Pfizer Inc Transaction History